Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Norio Watanabe, Keiko Yamamura, Yusuke Suzuki, Hiroyuki Umegaki, Katsuro Shigeno, Ryo Matsushita, Yoshimichi Sai, Ken-ichi Miyamoto & Kiyofumi Yamada. (2012) Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence. Patient Preference and Adherence 6, pages 605-611.
Read now
Read now
Articles from other publishers (10)
JungHyun Byun, Dong Yun Lee, Chang-Won Jeong, Yerim Kim, Hak Young Rhee, Ki Won Moon, Jeongwon Heo, Yoonki Hong, Woo Jin Kim, Seung-Joo Nam, Hoon Sung Choi, Ji In Park, In Kook Chun, So Hyeon Bak, Kyoungyul Lee, Gi Hwan Byeon, Kyoung Lae Kim, Jeong-Ah Kim, Young Joo Park, Jeong Hyun Kim, Eun ju Lee, Sang-Ah Lee, Sung Ok Kwon, Sang-Won Park, Payam Hosseinzadeh Kasani, Jung-Kyeom Kim, Yeshin Kim, Seongheon Kim & Jae-Won Jang. (2022) Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer’s dementia using OMOP CDM. Scientific Reports 12:1.
Crossref
Crossref
Anat Fisher, Greg Carney, Ken Bassett & Colin R. Dormuth. (2017) Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching. Drugs & Aging 34:3, pages 221-231.
Crossref
Crossref
Jens Bohlken, Simon Weber, Michael A. Rapp & Karel Kostev. (2015) Continuous treatment with antidementia drugs in Germany 2003–2013: a retrospective database analysis. International Psychogeriatrics 27:8, pages 1335-1342.
Crossref
Crossref
So-Hyeon Ahn, Nam-Kyong Choi, Ye-Jee Kim, Jong-Mi Seong, Ju-Young Shin, Sun-Young Jung & Byung-Joo Park. (2014) Drug persistency of cholinesterase inhibitors for patients with dementia of Alzheimer type in Korea. Archives of Pharmacal Research 38:6, pages 1255-1262.
Crossref
Crossref
Colleen J Maxwell, Kathryn Stock, Dallas Seitz & Nathan Herrmann. (2014) Persistence and Adherence with Dementia Pharmacotherapy: Relevance of Patient, Provider, and System Factors. The Canadian Journal of Psychiatry 59:12, pages 624-631.
Crossref
Crossref
Bernhard Haider, Reinhold Schmidt, Christine Schweiger, Thomas Forstner, Anna Labek & Christian Lampl. (2014) Medication Adherence in Patients With Dementia. Alzheimer Disease & Associated Disorders 28:2, pages 128-133.
Crossref
Crossref
Virginie Gardette, Maryse Lapeyre-Mestre, Antoine Piau, Adeline Gallini, Christelle Cantet, Jean-Louis Montastruc, Bruno Vellas & Sandrine Andrieu. (2014) A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe. CNS Drugs 28:2, pages 157-170.
Crossref
Crossref
Solin Saleh, Andrew Kirk, Debra G. Morgan & Chandima Karunanayake. (2014) Less Education Predicts Anticholinesterase Discontinuation in Dementia Patients. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40:5, pages 684-690.
Crossref
Crossref
David G Le Couteur, Maxine Robinson, Ann Leverton, Helen Creasey, Louise Waite, Kerry Atkins & Andrew J McLachlan. (2012) Adherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's disease. Australasian Journal on Ageing 31:3, pages 164-169.
Crossref
Crossref
Wontae Kim, Daeweon Lee, Jinkyu Choi, Ayoung Kim, Sangmi Han, Kwanho Park, Jiyoung Choi, Jonggil Kim, Youngcheol Choi, Si Hyeock Lee & Young Ho Koh. (2011) Pharmacogenetic Regulation of Acetylcholinesterase Activity in Drosophila Reveals the Regulatory Mechanisms of AChE Inhibitors in Synaptic Plasticity. Neurochemical Research 36:5, pages 879-893.
Crossref
Crossref